CSL Ltd - MACD Daily Histogram above 0 for 30 Consecutive DaysThe CSL Ltd (ASX:CSL) MACD Histogram (12, 26, 9) has just recorded 30 consecutive days above 0. Since 2000, this type of indicator persistence above 0 was usually the forerunner to some short-term relative outperformance.
The optimal 12-day average relative return vs All Ordinaries Index (ASX:XAO), following CSL's (12, 26, 9) MACD Daily Histogram above 0 for 30 consecutive days, was 3.52% with a relative win rate of 12 from 12, & standard deviation of 1.94%.
CSLLY trade ideas
Biotech - CSLModel has given entry signals for CSL Limited:
- CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions.
- We are very excited about opportunities in the biotech sector, as we believe the fight against COVID is going to move to the next phase in the nearest future.
- Technically in a Wyckoff accumulation structure with a spring, possibly testing the channel top.
GLHF,
DPT
Disclaimer:
We absolutely do not provide financial advice in any shape or form. We do not recommend investing based on our opinions and strongly cautions that securities trading and investment involves high risk and that you can lose a lot of money. Loss of principal is possible. We do not recommend risking money you cannot afford to lose. We do not guarantee future performance nor accuracy in historical analyses. We are not registered investment advisors. Our ideas, opinions and statements are not a substitute for professional investment advice. We provide ideas containing impersonal market observations and our opinions. Our speculations may be used in preparation to form your own ideas.
Good entry for CSL based off channel movementCSL has overhead resistance at $270, but i feel with this pull back, and following the channel, CSL will go through the resistance and push to $280 over the month. Vaccines are still being made and health is needed now coming into colder months. Entry here without a stop loss should be okay, chart is looking good, but if you want to stop loss at 15% below, would be safe and keep your emotions out of it.
CSL at resistance level.CSL at a resistance level that was march 2020 support after the big sell off. A consolidation of a week at these levels or below $270 will set a new uptrend. Because of the covid vaccine and government support, FA is lining up nicely with the TA movement.
Entry here with a stop at $250 is a good risk/reward trade.
CSL - A Potential buy Plan?CSL could be bottoming, as it appears so on the Weekly chart after it bounced off support with High Volume. Could it be a double bottom? Maybe, only time will tell. At this point, it seems that it may have bottomed medium term and may move higher. My trade plan is as follows:
TP1 - $270.00 (potential gain 6%)
TP2 - $288.00 (potential gain 13%)
Stoploss - $237.00
Please note these are my own notes, by no means trading advice. Please do your own research before entering into any trade.
ASX - CSLI have Several DCF analysis varying from a margin of safety price from $50-$200,
with such a great performing Aussie company you can not expect a pullback to the $50 area.
CSL has been operating for over 100 years and is still growing at 11% P.A
ROIC is close if not over the 20% mark.
There are 2 trend lines that I really for a pullback. But i won't miss the boat if it touches the $202 per/share price.
CSL - Slowly Forming Bullish Pennant Price action suggests continuation of consolidation. Break out to upside will likely occur on positive vaccine news, or profitability numbers, or resumption of blood collection sites..or when this bullish pennant reaches the peak and sellers get exhausted.
We are above MAs as well
Bullish Pennant Forming - Prime for Breakout! Technically, forming a bullish pennant.
Fundamentally, CSL will be the provider of the vaccine, even with the recent losses in blood donors, this carries bullish sentiment.
I'm predicting a large breakout some time in Late January, or Feb.
Also, as you can see, it's consolidating on the RSI.
IMO the stock consolidates until then, then we should see it go higher